Study finds Guardant’s liquid biopsy adept at detecting biomarker used by Merck immunotherapy drug
The study, by US and Korean researchers, found Guardant360's detection of MSI-H/dMMR "highly concordant" with that of standard tissue biopsy, including in a subset of gastric cancer patients who responded to immunotherapy.